We also found that plasma dopamine beta-hydroxylase (DBH) concentrations increased in responders from 4 to 10 weeks, consistent with low plasma DBH levels associated with low activity of the noradrenaline system in patients with depression [62,63,64,65,66]. Here, DBH is linked to major depressive disorder.